Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 11, Supplement 1, 2000   [Index by Author] 


Down Introduction
Down Symposium Articles


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Introduction Back

E. Zucca and E. Roggero
The seventh Lugano conference — basic science, translational and clinical research in the lymphoma field: The challenge goes on
Ann Oncol 2000 11: S1; doi:10.1093/annonc/11.suppl_1.S1 [PDF] [Request Permissions]  

Symposium Articles Back

N. L. Harris, E. S. Jaffe, J. Diebold, G. Flandrin, H. K. Muller-Hermelink, and J. Vardiman
Lymphoma classification – from controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms
Ann Oncol 2000 11: S3-S10; doi:10.1093/annonc/11.suppl_1.S3 [Abstract] [PDF] [Request Permissions]  

R. Willemze and C. J. L. M. Meijer
EORTC Classification for primary cutaneous lymphomas: A comparison with the R.E.A.L. Classification and the proposed WHO Classification
Ann Oncol 2000 11: S11-S15; doi:10.1093/annonc/11.suppl_1.S11 [Abstract] [PDF] [Request Permissions]  

E. S. Jaffe, C. A. Sander, and M. J. Flaig
Cutaneous lymphomas: A proposal for a unified approach to classification using the R.E.A.L./WHO Classification
Ann Oncol 2000 11: S17-S21; doi:10.1093/annonc/11.suppl_1.S17 [Abstract] [PDF] [Request Permissions]  

S. J. Horning
Follicular lymphoma: Have we made any progress?
Ann Oncol 2000 11: S23-S27; doi:10.1093/annonc/11.suppl_1.S23 [Abstract] [PDF] [Request Permissions]  

R. I. Fisher
Diffuse large-cell lymphoma
Ann Oncol 2000 11: S29-S33; doi:10.1093/annonc/11.suppl_1.S29 [Abstract] [PDF] [Request Permissions]  

R. E. Hutchison, C. Finch, J. Kepner, C. Fuller, P. Bowman, M. Link, M. Schwenn, J. Laver, S. Desai, D. Barrett, and S. B. Murphy
Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons
Ann Oncol 2000 11: S35-S38; doi:10.1093/annonc/11.suppl_1.S35 [Abstract] [PDF] [Request Permissions]  

J.-Y. Blay, P. Ongolo-Zogo, C. Sebban, C. Carrie, P. Thiesse, and P. Biron for the FNCLCC
Primary cerebral lymphomas: Unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses
Ann Oncol 2000 11: S39-S44; doi:10.1093/annonc/11.suppl_1.S39 [Abstract] [PDF] [Request Permissions]  

L. J. Swinnen
Diagnosis and treatment of transplant-related lymphoma
Ann Oncol 2000 11: S45-S48; doi:10.1093/annonc/11.suppl_1.S45 [Abstract] [PDF] [Request Permissions]  

P. Dreger, M. Michallet, and N. Schmitz
Stem-cell transplantation for chronic lymphocytic leukemia: The 1999 perspective
Ann Oncol 2000 11: S49-S53; doi:10.1093/annonc/11.suppl_1.S49 [Abstract] [PDF] [Request Permissions]  

R. A. Kyle
The role of high-dose chemotherapy in the treatment of multiple myeloma: A controversy
Ann Oncol 2000 11: S55-S58; doi:10.1093/annonc/11.suppl_1.S55 [Abstract] [PDF] [Request Permissions]  

C. L. Toze, J. D. Shepherd, J. M. Connors, N. J. Voss, R. D. Gascoyne, D. E. Hogge, H. G. Klingemann, S. H. Nantel, T. J. Nevill, G. L. Phillips, D. E. Reece, H. J. Sutherland, E. A. Conneally, and M. J. Barnett
Allografting for indolent lymphoid neoplasms
Ann Oncol 2000 11: S59-S61; doi:10.1093/annonc/11.suppl_1.S59 [Abstract] [PDF] [Request Permissions]  

K. N. Naresh, V. Srinivas, and C. S. Soman
Distribution of various subtypes of non-Hodgkin's lymphoma in India: A study of 2773 lymphomas using R.E.A.L. and WHO Classifications
Ann Oncol 2000 11: S63-S67; doi:10.1093/annonc/11.suppl_1.S63 [Abstract] [PDF] [Request Permissions]  

Y. Mao, J. Hu, A.-M. Ugnat, and K. White for the Canadian Cancer Registries Epidemiology Research Group
Non-Hodgkin's lymphoma and occupational exposure to chemicals in Canada
Ann Oncol 2000 11: S69-S73; doi:10.1093/annonc/11.suppl_1.S69 [Abstract] [PDF] [Request Permissions]  

O. Paltiel, A. Zelenetz, I. Sverdlin, L. Gordon, and D. Ben-Yehuda
Translocation t(14;18) in healthy individuals: Preliminary study of its association with family history and agricultural exposure
Ann Oncol 2000 11: S75-S80; doi:10.1093/annonc/11.suppl_1.S75 [Abstract] [PDF] [Request Permissions]  

M. Sieber, A. Engert, and V. Diehl
Treatment of Hodgkin's disease: Results and current concepts of the German Hodgkin's Lymphoma Study Group
Ann Oncol 2000 11: S81-S85; doi:10.1093/annonc/11.suppl_1.S81 [Abstract] [PDF] [Request Permissions]  

D. C. Linch, P. Smith, B. W. Hancock, P. J. Hoskin, D. C. Cunningham, A. C. Newland, D. Milligan, P. A. Stevenson, J. K. Wood, K. A. Maclennan, B. Vaughan Hudson, G. Vaughan Hudson, and W. M. Gregory
A Randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma
Ann Oncol 2000 11: S87-S90; doi:10.1093/annonc/11.suppl_1.S87 [Abstract] [PDF] [Request Permissions]  

H. C. Schouten, S. Kvaloy, M. Sydes, W. Qian, and P. M. Fayers on behalf of the CUP trial investigators
The CUP trial: A randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)
Ann Oncol 2000 11: S91-S94; doi:10.1093/annonc/11.suppl_1.S91 [Abstract] [PDF] [Request Permissions]  

T. Linnemann, K.-H. Wiesmüller, S. Gellrich, K. Kaltoft, W. Sterry, and P. Walden
A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma
Ann Oncol 2000 11: S95-S99; doi:10.1093/annonc/11.suppl_1.S95 [Abstract] [PDF] [Request Permissions]  

T. A. Waldmann
T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma
Ann Oncol 2000 11: S101-S106; doi:10.1093/annonc/11.suppl_1.S101 [Abstract] [PDF] [Request Permissions]  

S. P. Treon, Y. Shima, M. L. Grossbard, F. I. Preffer, A. R. Belch, L. M. Pilarski, and K. C. Anderson
Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens
Ann Oncol 2000 11: S107-S111; doi:10.1093/annonc/11.suppl_1.S107 [Abstract] [PDF] [Request Permissions]  

N. Milpied, B. Vasseur, N. Parquet, J. L. Garnier, C. Antoine, P. Quartier, A. S. Carret, D. Bouscary, A. Faye, B. Bourbigot, Y. Reguerre, A. M. Stoppa, P. Bourquard, B. Hurault de Ligny, F. Dubief, A. Mathieu-Boue, and V. Leblond
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
Ann Oncol 2000 11: S113-S116; doi:10.1093/annonc/11.suppl_1.S113 [Abstract] [PDF] [Request Permissions]  

J. M. Foran, D. Cunningham, B. Coiffier, P. Solal-Celigny, F. Reyes, M. Ghielmini, P. W. M. Johnson, C. Gisselbrecht, M. Bradburn, J. Matthews, and T. A. Lister
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response
Ann Oncol 2000 11: S117-S121; doi:10.1093/annonc/11.suppl_1.S117 [Abstract] [PDF] [Request Permissions]  

M. Ghielmini, S.-F. Hsu Schmitz, K. Bürki, G. Pichert, D. C. Betticher, R. Stupp, M. Wernli, A. Lohri, D. Schmitter, F. Bertoni, and T. Cerny for the Swiss Group for Clinical Cancer Research (SAKK)
The effect of Rituximab on patients with follicular and mantle-cell lymphoma
Ann Oncol 2000 11: S123-S126; doi:10.1093/annonc/11.suppl_1.S123 [Abstract] [PDF] [Request Permissions]  

S. Stilgenbauer, C. Schaffner, D. Winkler, G. Ott, E. Leupolt, M. Bentz, P. Möller, H. K. Müller-Hermelink, M. R. James, P. Lichter, and H. Döhner
The ATM gene in the pathogenesis of mantle-cell lymphoma
Ann Oncol 2000 11: S127-S130; doi:10.1093/annonc/11.suppl_1.S127 [Abstract] [PDF] [Request Permissions]  

M. Chesi, W. M. Kuehl, and P. L. Bergsagel
Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma
Ann Oncol 2000 11: S131-S135; doi:10.1093/annonc/11.suppl_1.S131 [Abstract] [PDF] [Request Permissions]  

A. López-Guillermo, F. Cabanillas, P. McLaughlin, T. Smith, F. Hagemeister, M. A. Rodriguez, J. E. Romaguera, A. Younes, A. H. Sarris, H. A. Preti, W. Pugh, and M.-S. Lee
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series
Ann Oncol 2000 11: S137-S140; doi:10.1093/annonc/11.suppl_1.S137 [Abstract] [PDF] [Request Permissions]  

K. Seidemann, G. Henze, J. D. Beck, A. Sauerbrey, J. Kühl, G. Mann, and A. Reiter
Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials
Ann Oncol 2000 11: S141-S145; doi:10.1093/annonc/11.suppl_1.S141 [Abstract] [PDF] [Request Permissions]  

N. G. Mikhaeel, A. R. Timothy, S. F. Hain, and M. J. O'Doherty
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
Ann Oncol 2000 11: S147-S150; doi:10.1093/annonc/11.suppl_1.S147 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.